Tackling Antimicrobial Resistance Behaviour Within and Beyond the Healthcare Setting

Drug-resistant tuberculosis (DR-TB) is a major threat to global public health, causing one in four estimated worldwide deaths attributable to antimicrobial resistance.

In South Africa, DR-TB transmission within clinics, particularly to HIV positive people, is well-documented. Most TB transmission happens before people start TB treatment, but DR-TB transmission may continue after treatment is started, raising concern as DR-TB services in South Africa are decentralised from hospitals to primary care clinics. The extent to which exposure in clinics, as compared to other community settings, drives ongoing transmission of DR-TB requires better definition, to mobilise necessary resources to address this problem. Guidelines for clinics concerning infection prevention and control (IPC) measures to reduce DR-TB transmission are widely available. There is ample evidence that recommended measures are not put into practice, but limited understanding of the reasons. A comprehensive approach to understanding barriers to implementation is required to design effective IPC interventions for DR-TB.


Key contacts

Image of Janine Shaw

Janine Shaw

Senior Project Support Officer


+44 1273 915782

Project details

start date
1 August 2017
end date
31 July 2020


Supported by

About this project


Image of Annie Lowden

Annie Lowden

Project Manager

Image of Elin Morris

Elin Morris

Project Support Officer

Image of Hayley MacGregor

Hayley MacGregor

Research Fellow

Louise Korda

Finance Assistant